This inventor holds 4 USPTO granted patents. Top assignees: Innogenetics N.v., N.v. Innogenetics S.a.. Active years: 2000-2006.
Company Filing History:
Years Active: 2000-2006
Title: Guy De Martynoff: Innovator in Hepatitis C Research
Introduction
Guy De Martynoff is a notable inventor based in Waterloo, Belgium. He has made significant contributions to the field of medical research, particularly in the area of hepatitis C virus (HCV) diagnostics and therapeutics. With a total of 4 patents to his name, his work has the potential to impact the treatment and monitoring of HCV.
Latest Patents
One of his latest patents focuses on "Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use." This invention describes a method for purifying recombinant HCV envelope proteins, specifically E1 and/or E1/E2. The process involves lysing transformed host cells to isolate the recombinantly expressed protein, followed by a disulphide bond cleavage or reduction step using a disulphide bond cleavage agent. The patent also covers the diagnostic and therapeutic applications of these compositions, as well as the use of HCV E1 protein and peptides for prognosing and monitoring the clinical effectiveness and outcomes of HCV treatment.
Career Highlights
Throughout his career, Guy De Martynoff has worked with prominent companies in the biotechnology sector, including Innogenetics N.V. and N.V. Innogenetics S.A. His expertise in the field has allowed him to contribute to advancements in HCV research and treatment.
Collaborations
Guy has collaborated with notable colleagues such as Geert Maertens and Fons Bosman. Their combined efforts have furthered the understanding and treatment of hepatitis C.
Conclusion
Guy De Martynoff's innovative work in the field of hepatitis C research exemplifies the impact of dedicated inventors in advancing medical science. His patents and collaborations continue to pave the way for improved diagnostic and therapeutic options for HCV.